Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dora E Wiskirchen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Family Practice|February 3, 2017
Antibiotic stewardship: The FP's roleDora E Wiskirchen, Maria Summa, Adam Perrin
International Journal of Antimicrobial Agents|April 25, 2013
Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniaeDora E Wiskirchen, Jared L Crandon, David P Nicolau
Journal of Pharmaceutical Sciences|November 3, 2006
Iontophoretic drug delivery across human nailS Narasimha Murthy, Dora E Wiskirchen, Christopher Paul Bowers
The Journal of Family Practice|February 6, 2018
Inpatient antibiotic resistance: Everyone's problemDora E Wiskirchen, Ulysses Wu, Maria Summa, et al.
Surgical Infections|October 19, 2011
Acute physiology and chronic health evaluation II score is a better predictor of mortality than IBMP-10 in patients with ventilator-associated pneumoniaDora E Wiskirchen, Joseph L Kuti, David P Nicolau
Journal of the American Podiatric Medical Association|December 16, 2015
Antibiotic Tissue Penetration in Diabetic Foot Infections A Review of the Microdialysis Literature and Needs for Future ResearchAmanda Ray, Danielle Malin, David P Nicolau, et al.
Antimicrobial Agents and Chemotherapy|June 5, 2013
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection modelDora E Wiskirchen, Patrice Nordmann, Jared L Crandon, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2014
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing EnterobacteriaceaeDora E Wiskirchen, Patrice Nordmann, Jared L Crandon, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2014
Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection modelDora E Wiskirchen, Patrice Nordmann, Jared L Crandon, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysisDora E Wiskirchen, Ashley Shepard, Joseph L Kuti, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Family Practice|February 3, 2017
Antibiotic stewardship: The FP's roleDora E Wiskirchen, Maria Summa, Adam Perrin
International Journal of Antimicrobial Agents|April 25, 2013
Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniaeDora E Wiskirchen, Jared L Crandon, David P Nicolau
Journal of Pharmaceutical Sciences|November 3, 2006
Iontophoretic drug delivery across human nailS Narasimha Murthy, Dora E Wiskirchen, Christopher Paul Bowers
The Journal of Family Practice|February 6, 2018
Inpatient antibiotic resistance: Everyone's problemDora E Wiskirchen, Ulysses Wu, Maria Summa, et al.
Surgical Infections|October 19, 2011
Acute physiology and chronic health evaluation II score is a better predictor of mortality than IBMP-10 in patients with ventilator-associated pneumoniaDora E Wiskirchen, Joseph L Kuti, David P Nicolau
Journal of the American Podiatric Medical Association|December 16, 2015
Antibiotic Tissue Penetration in Diabetic Foot Infections A Review of the Microdialysis Literature and Needs for Future ResearchAmanda Ray, Danielle Malin, David P Nicolau, et al.
Antimicrobial Agents and Chemotherapy|June 5, 2013
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection modelDora E Wiskirchen, Patrice Nordmann, Jared L Crandon, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2014
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing EnterobacteriaceaeDora E Wiskirchen, Patrice Nordmann, Jared L Crandon, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2014
Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection modelDora E Wiskirchen, Patrice Nordmann, Jared L Crandon, et al.
Antimicrobial Agents and Chemotherapy|June 29, 2011
Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysisDora E Wiskirchen, Ashley Shepard, Joseph L Kuti, et al.
Pageof 2